Greenwich LifeSciences In...

11.70
-0.52 (-4.26%)
At close: Mar 03, 2025, 3:59 PM
11.70
0.00%
After-hours: Mar 03, 2025, 04:00 PM EST

Greenwich LifeSciences Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Revenue n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue 3.61K 3.61K 3.61K 3.61K 3.61K 3.61K 3.61K
Gross Profit -3.61K -3.61K -3.61K -3.61K -3.61K -3.61K -3.61K
Operating Income -9.33M -8.04M -4.6M -1.86M -3.43M -1.69M -1.57M
Interest Income 436.06K 215.02K 27.37K 832.00 n/a n/a n/a
Pretax Income -8.89M -7.83M -4.57M -1.86M -3.43M -1.69M -1.57M
Net Income -8.89M -7.61M -4.54M -1.86M -3.43M -1.69M -1.57M
Selling & General & Admin 1.63M 1.56M 1.04M 806.19K 818.89K 419.64K 346.81K
Research & Development 7.7M 6.48M 3.56M 1.06M 2.61M 1.27M 1.22M
Other Expenses -0.00 n/a n/a n/a n/a n/a n/a
Operating Expenses 9.33M 8.04M 4.6M 1.86M 3.43M 1.69M 1.57M
Interest Expense n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 9.33M 8.04M 4.6M 1.86M 3.43M 1.69M 1.57M
Income Tax n/a -215.02K -27.37K -832 3.00 -157.53K 3.00
Shares Outstanding (Basic) 12.85M 12.91M 12.94M 12.7M 11.74M 11.97M 11.74M
Shares Outstanding (Diluted) 12.85M 12.91M 12.94M 12.7M 11.74M 11.97M 11.74M
EPS (Basic) -0.69 -0.59 -0.35 -0.15 -0.29 -0.14 -0.13
EPS (Diluted) -0.69 -0.59 -0.35 -0.15 -0.29 -0.14 -0.13
EBITDA -9.32M -8.04M -4.59M -1.86M -3.42M -1.69M -1.57M
Depreciation & Amortization 3.61K 3.61K 3.61K 3.61K 3.61K 3.61K 3.61K